China Medical System Holdings Limited (HKG:0867)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
11.98
-0.18 (-1.48%)
Aug 11, 2026, 3:05 PM HKT

HKG:0867 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,4891,6202,4013,2593,017
Depreciation & Amortization
266.93259.24229.57227.23219.82
Other Amortization
--23.45--
Loss (Gain) From Sale of Assets
-18.73-0.50.270.40.23
Asset Writedown & Restructuring Costs
31.741.15171.496220
Loss (Gain) From Sale of Investments
-210.99109.0360.75-150.01-115.66
Loss (Gain) on Equity Investments
-242.3-341.3-277.87-65.06-75.35
Stock-Based Compensation
27.31--35.8718.7217.16
Provision & Write-off of Bad Debts
1.72-0.552.720.111.31
Other Operating Activities
62.62-250.21-125.56110.795.03
Change in Accounts Receivable
-446.76-173.42410.56163.91-367.89
Change in Inventory
-55.91-130.5-235.778.16-90.87
Change in Accounts Payable
22.7747.82-82.85-71.86-33.87
Change in Unearned Revenue
-4.483.88-8.88-2.19.31
Change in Other Net Operating Assets
-164.41124.08-80.1-8.04-112.77
Operating Cash Flow
758.421,2692,5033,5532,494
Operating Cash Flow Growth
-40.21%-49.32%-29.56%42.48%-7.36%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-41.04-32.62-27.49-18.34-23.35
Sale of Property, Plant & Equipment
1.374.090.322.323
Cash Acquisitions
----29-533.91
Divestitures
34.99--11.16--
Sale (Purchase) of Intangibles
-473.37-423.29-275.77-506.59-161.49
Investment in Securities
-797.97-403.8-470.14-726.06-898.54
Other Investing Activities
339.69312.75341.96134.27126.64
Investing Cash Flow
-984.32-615.1-442.28-1,178-1,520

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
682.52831.31,2771,3751,077
Total Debt Issued
682.52831.31,2771,3751,077
Long-Term Debt Repaid
-880.96-1,296-1,805-1,445-11.81
Total Debt Repaid
-880.96-1,296-1,805-1,445-11.81
Net Debt Issued (Repaid)
-198.45-465.07-528.26-69.831,066
Repurchase of Common Stock
--238.39--48.38-151.52
Common Dividends Paid
-660.56-556.16-1,360-1,276-1,155
Other Financing Activities
88.07-1.42-236.4-5.46-17.61
Financing Cash Flow
-770.94-1,261-2,125-1,400-258.39

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-8.283.04-0.8715.511.38
Net Cash Flow
-1,005-604.56-65.32990.64717.31

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
717.381,2362,4753,5352,471
Free Cash Flow Growth
-41.96%-50.07%-29.97%43.08%-6.93%
Free Cash Flow Margin
8.74%16.55%30.89%38.63%29.63%
Free Cash Flow Per Share
0.300.511.011.441.00
Levered Free Cash Flow
212.65544.941,5512,0911,350
Unlevered Free Cash Flow
225.34569.071,5802,1221,368

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
20.338.6145.2137.5517.61
Cash Income Tax Paid
482.54538.55547.05450.5396.73
Change in Working Capital
-648.78-128.152.9790.08-596.07